Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,646,085 shares of a nominal value of DKK 31,292,170, equivalent to 4.99% of Novozymes A/S’ share capital and 1.96% of the voting rights.
Major shareholder announcement
In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes to 4.99%, previously reported at 7.45% in company announcement no. 25, November 2013.
| Quelle: Novonesis (Novozymes A/S)
Anhänge
